These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38752748)

  • 101. Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
    Martin IW; Tonner R; Trivedi J; Miller H; Lee R; Liang X; Rotello L; Isenbergh E; Anderson J; Perl T; Zhang SX
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):286-288. PubMed ID: 28024866
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Probiotic Yeasts: A Developing Reality?
    Tullio V
    J Fungi (Basel); 2024 Jul; 10(7):. PubMed ID: 39057374
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Beneficial effects of
    Terciolo C; Dapoigny M; Andre F
    Clin Exp Gastroenterol; 2019; 12():67-82. PubMed ID: 30804678
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Growth and survival of microencapsulated probiotics prepared by emulsion and internal gelation.
    Qi W; Liang X; Yun T; Guo W
    J Food Sci Technol; 2019 Mar; 56(3):1398-1404. PubMed ID: 30956319
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
    Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
    Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
    [TBL] [Abstract][Full Text] [Related]  

  • 106. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
    Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
    Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A Mutation in
    Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
    Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Microbiome Engineering Using Probiotic Yeast:
    Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
    Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Enhancing probiotic impact: engineering
    de Carvalho BT; Subotić A; Vandecruys P; Deleu S; Vermeire S; Thevelein JM
    Appl Environ Microbiol; 2024 Jun; 90(6):e0032524. PubMed ID: 38752748
    [No Abstract]   [Full Text] [Related]  

  • 110. Yeasts as probiotics: Mechanisms, outcomes, and future potential.
    Sen S; Mansell TJ
    Fungal Genet Biol; 2020 Apr; 137():103333. PubMed ID: 31923554
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
    Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
    Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
    [TBL] [Abstract][Full Text] [Related]  

  • 112.
    Pais P; Almeida V; Yılmaz M; Teixeira MC
    J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32512834
    [No Abstract]   [Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.